Evaluation of the presence of clinically significant hemolytic disease of the fetus and newborn due to RhD antibodies in multi-ethnic Suriname

R. Zonneveld; H. Schonewille; A.L. Brand; H.H.H. Kanhai; C.W.R. Zijlmans

doi:10.1016/j.aogh.2016.04.674

Evaluation of the presence of clinically significant hemolytic disease of the fetus and newborn due to RhD antibodies in multi-ethnic Suriname

Annals of Global Health

Volume 82 (2016): Issue 3

By: R. Zonneveld, H. Schonewille, A.L. Brand, H.H.H. Kanhai and C.W.R. Zijlmans

Open Access

|Aug 2016

Authors

R. Zonneveld

philip.landrigan@mssm.edu

Scientific Research Center Suriname, Academic Hospital Paramaribo, Suriname; Department of Pediatrics, Academic Hospital Paramaribo, Suriname

H. Schonewille

philip.landrigan@mssm.edu

Department of Research, Sanquin Blood Supply, Amsterdam, The Netherlands

A.L. Brand

philip.landrigan@mssm.edu

Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands

H.H.H. Kanhai

philip.landrigan@mssm.edu

Department of Obstetrics, Leiden University Medical Center, Leiden, The Netherlands

C.W.R. Zijlmans

philip.landrigan@mssm.edu

Scientific Research Center Suriname, Academic Hospital Paramaribo, Suriname; Department of Pediatrics, Diakonessen Hospital, Paramaribo, Suriname

DOI: https://doi.org/10.1016/j.aogh.2016.04.674 | Journal eISSN: 2214-9996

Journal RSS Feed

Language: English

Published on: Aug 20, 2016

Published by: Ubiquity Press

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

© 2016 R. Zonneveld, H. Schonewille, A.L. Brand, H.H.H. Kanhai, C.W.R. Zijlmans, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous article Volume 82 (2016): Issue 3 Next article